학술논문
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia September 2023 23(9):674-686
Subject
Language
ISSN
2152-2650